Type 1 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 1 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-11-15FDA Approved: TOUJEO — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for Toujeo (insulin glargine) from Sanofi-Aventis U.S. LLC.
-
FDA approval · 2019-11-15FDA Approved: ADMELOG — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for ADMELOG (insulin lispro) submitted by Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2019-11-15Clinical Trial Update: Single Ascending Dose Study of MK-1092 in Healthy Participants and in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-1092-001) [Phase 1]
Phase 1 single ascending dose study of MK-1092 in healthy participants and in individuals with Type 1 and Type 2 diabetes completed with res…
-
CLINICAL_TRIALS trial_result · 2019-11-14Clinical Trial Update: Medtronic Minimed Overnight Closed-Loop System [NA]
Clinical trial update for Medtronic Minimed Overnight Closed-Loop System; completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-11-14Clinical Trial Update: Anti-inflammatory Therapy With Anakinra in Newly Diagnosed Type 1 Diabetes [Phase 1, Phase 2]
A clinical trial investigating anakinra (an anti-inflammatory IL-1 receptor antagonist) in newly diagnosed type 1 diabetes has completed pha…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-11-06Clinical Trial Update: Study of MiniMed™ 640G Insulin Pump With SmartGuard™ in Prevention of Low Glucose Events in Adults With Type 1 Diabetes [NA]
Clinical trial update on the MiniMed 640G insulin pump with SmartGuard in adults with Type 1 diabetes; status completed with results posted …
-
CLINICAL_TRIALS research · 2019-11-01Clinical Trial Update: Clinical Assessment of a Closed-loop System With Glucagon, Exercise and Mixed Meals [NA]
A completed clinical trial studying a closed-loop system that uses glucagon with exercise and mixed meals in Type 1 Diabetes.
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy [Phase 3]
Phase 3 trial evaluating sotagliflozin as an adjunct to insulin in adults with Type 1 Diabetes; study completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: Dose-ranging Study in Patients With Type 1 Diabetes Mellitus [Phase 2]
A Phase 2 dose-ranging study in patients with Type 1 Diabetes Mellitus has completed; results were posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: Safety and Efficacy of Sotagliflozin (LX4211) in Patients With Inadequately Controlled Type 1 Diabetes Mellitus [Phase 2]
Phase 2 trial assessing safety and efficacy of sotagliflozin in patients with inadequately controlled type 1 diabetes mellitus completed wit…
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: Efficacy and Safety of Sotagliflozin in Young Adult Patients With Type 1 Diabetes Mellitus and Elevated Hemoglobin A1C [Phase 2]
Phase 2 trial update evaluating the efficacy and safety of sotagliflozin in young adults with Type 1 Diabetes Mellitus and elevated HbA1c; s…
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes [Phase 2]
Phase II trial assessing subcutaneous exenatide (Bydureon) for glucose control in adults with Type I diabetes has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: Accelerometer Use in the Prevention of Exercise-Associated Hypoglycemia in Type 1 Diabetes: Outpatient Exercise Protocol [NA]
Completed clinical trial on using accelerometer-guided exercise protocols to prevent exercise-associated hypoglycemia in individuals with Ty…
-
FDA approval · 2019-10-21FDA Approved: FIASP — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for FIASP (insulin aspart injection) submitted by Novo Nordisk, updating the labeling.
-
CLINICAL_TRIALS trial_result · 2019-10-18Clinical Trial Update: Sleep Promotion to Improve Diabetes Management in Adolescents With T1D [NA]
A completed clinical trial investigating whether sleep promotion improves diabetes management in adolescents with Type 1 diabetes.
-
CLINICAL_TRIALS trial_result · 2019-10-15Clinical Trial Update: DPP4inhibitors in Type 1 Diabetes [Phase 3]
Phase 3 clinical trial update on DPP4 inhibitors for Type 1 Diabetes and hypoglycemia outcomes; study completed.
-
CLINICAL_TRIALS trial_result · 2019-10-14Clinical Trial Update: A Study of Single or Repeated Doses of Glucagon in Participants With Diabetes [Phase 1]
Phase 1 trial evaluating single or repeated doses of glucagon in participants with diabetes completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-14Clinical Trial Update: Use of Diazoxide in Acute Hypoglycaemia [Phase 4]
Phase 4 clinical trial update on the use of diazoxide for acute hypoglycemia in Type 1 diabetes.
-
CLINICAL_TRIALS trial_result · 2019-10-11Clinical Trial Update: Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH [NA]
A terminated clinical trial comparing the duration of the honeymoon phase in type 1 diabetes among insulin detemir, insulin glargine, and NP…
-
CLINICAL_TRIALS trial_result · 2019-10-11Clinical Trial Update: Hyaluronidase Effect on Infusion Set Life [Phase 1]
Phase 1 clinical trial updating hyaluronidase effect on infusion set life in Type 1 Diabetes Mellitus; results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes [Phase 3]
Phase 3 trial update for LY900014 with insulin lispro using an external insulin infusion in adults with type 1 diabetes; trial completed wit…
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: Equivalence of A Stable Liquid Glucagon Formulation With Freshly Reconstituted Lyophilized Glucagon [Phase 2, Phase 3]
Phase 2/3 trial updating equivalence of a stable liquid glucagon formulation with freshly reconstituted lyophilized glucagon in type 1 diabe…
-
CLINICAL_TRIALS withdrawal · 2019-10-08Clinical Trial Update: Immunogenicity Safety Study of Wockhardt's Recombinant Insulin Analogue in Type 1 Diabetic Patients [Phase 3]
A Phase 3 immunogenicity and safety study of Wockhardt's recombinant insulin analogue in Type 1 diabetes has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-09-25Clinical Trial Update: EDCR Study - Etanercept Diamyd Combination Regimen -Open Trial to Evaluate Safety in Children With Type 1 Diabetes [Phase 2]
Phase 2 open trial evaluating safety of a combination regimen (Etanercept Diamyd) in children with Type 1 diabetes; study completed with res…
-
CLINICAL_TRIALS trial_result · 2019-09-23Clinical Trial Update: A Study of Nasal Glucagon in Participants With Type 1 Diabetes Mellitus [Phase 1]
Phase 1 trial evaluating nasal glucagon in participants with type 1 diabetes completed with results posted.